FluoSphera raises €900K Pre-Seed round
9 March 2023· Geneva, Switzerland· health, biotech, drug_discovery, ai, preclinical_testing, b2b, software_hardware
FluoSphera will develop its unique technology platform to provide the pharma industry with unprecedented solutions to improve drug discovery.
Investors
LeadIndieBio New York (part of SOSV)
Also participating
Mountain LabsEFI Lake Geneva Venturesprivate business angels
About FluoSphera
Stage
Seed
Headquarters
Geneva, Switzerland
Founded
2021
Team Size
1–5
Sectors
healthbiotechdrug_discoveryaipreclinical_testingb2bsoftware_hardware